Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Usama M. Fouda, Hesham S. Elshaer, Gamal G. Youssef, Amal Hanafy, Waleed M. Mehrem, Mohamed A. Youssef, Mona Farouk & Hala Nabil. (2022) Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study. Journal of Obstetrics and Gynaecology 42:1, pages 122-126.
Read now
Read now
Remzi Atilgan, Şehmus Pala, Şeyda Yavuzkır, Melike Başpınar, Mustafa Yılmaz & Nevin Ilhan. (2019) What is the impact of short- and long-term supplementation of either cabergoline or clarithromycin on resolving rat ovarian hyperstimulation syndrome (OHSS) model?. Journal of Obstetrics and Gynaecology 39:5, pages 687-694.
Read now
Read now
Samettin Celik, Canan Soyer-Calıskan, Safak Hatirnaz, Handan Celik, Miğraci Tosun & Ebru S. Hatirnaz. (2019) Lifesaving dose increment of cabergoline in life-threatening spontaneous ovarian hyperstimulation syndrome resistant to all interventions. Gynecological Endocrinology 35:4, pages 287-289.
Read now
Read now
Vito Cela, Maria Elena Rosa Obino, Ylenia Alberga, Sara Pinelli, Claudia Sergiampietri, Elena Casarosa, Giovanna Simi, Francesca Papini & Paolo Giovanni Artini. (2018) Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes. Gynecological Endocrinology 34:6, pages 518-523.
Read now
Read now
Miro Kasum, Hrvoje Vrčić, Patrik Stanić, Davor Ježek, Slavko Orešković, Lidija Beketić-Orešković & Marijeta Pekez. (2014) Dopamine agonists in prevention of ovarian hyperstimulation syndrome. Gynecological Endocrinology 30:12, pages 845-849.
Read now
Read now
Articles from other publishers (24)
Mohamed Youssef, Abdel-Maguid Ramzy & Botros Rizk. 2022. Ovarian Stimulation. Ovarian Stimulation
141
157
.
Dalia Khalife, Suleiman Ghunaim, LinaEl Taha, Omar Odeh, Natasha Habr & Johnny Awwad. (2022) Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze-all strategy: A case report and review of the literature. Asian Pacific Journal of Reproduction 11:6, pages 292.
Crossref
Crossref
Eryn Sara Rubenfeld & Michael Haim Dahan. (2021) Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?. Obstetrics & Gynecology Science 64:4, pages 345-352.
Crossref
Crossref
Huilin Tang, Selma M. Mourad, Aihua Wang, Suo-Di Zhai & Roger J Hart. (2021) Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Konstantinos Tserotas & José Luis Neyro. 2021. Obstetric Catastrophes. Obstetric Catastrophes
151
167
.
Maria Elisabetta Coccia, Francesca Rizzello & Giulia Orlandi. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
263
284
.
Maria Elisabetta Coccia, Francesca Rizzello & Giulia Orlandi. 2020. Female Reproductive Dysfunction. Female Reproductive Dysfunction
1
22
.
Mustafa Taş & Bülent Özçelik. (2019) Does the combination of myo-inositol improve pregnancy outcomes in obese polycystic ovary syndrome women undergoing ovarian stimulation with clomiphene citrate?. Journal of Surgery and Medicine.
Crossref
Crossref
Sherif Gaafar, Dalal El-Gezary & Hassan A. El Maghraby. (2019) Early onset of cabergoline therapy for prophylaxis from ovarian hyperstimulation syndrome (OHSS): A potentially safer and more effective protocol. Reproductive Biology 19:2, pages 145-148.
Crossref
Crossref
Ahmed Samy Saad & Khalid Abd Aziz Mohamed. (2017) Diosmin versus cabergoline for prevention of ovarian hyperstimulation syndrome. Middle East Fertility Society Journal 22:3, pages 206-210.
Crossref
Crossref
Selma Mourad, Julie Brown & Cindy Farquhar. (2017) Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Crossref
Lukasz T. Polanski & Miriam N. Baumgarten. 2017. Clinical Management of Pregnancies following ART. Clinical Management of Pregnancies following ART
81
100
.
Usama M. Fouda, Ahmed M. Sayed, Hesham S. Elshaer, Bahaa Eldin M. Hammad, Mona M. Shaban, Khaled A. Elsetohy & Mohamed A. Youssef. (2016) GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial. Journal of Ovarian Research 9:1.
Crossref
Crossref
M. Kollmann, W. P. Martins, M. L. S. Lima, L. Craciunas, C. O. Nastri, A. Richardson & N. Raine-Fenning. (2016) Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology 48:6, pages 709-718.
Crossref
Crossref
Huilin Tang, Selma Mourad, Suo-Di Zhai & Roger J Hart. (2016) Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kazem Nouri, Johannes Ott, Christian Lenart, Katharina Walch, Regina Promberger & Clemens B. Tempfer. (2016) Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study. Gynecologic and Obstetric Investigation 81:6, pages 504-511.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
13
.
Robert F. Casper. (2015) Reducing the Risk of OHSS by GnRH Agonist Triggering. The Journal of Clinical Endocrinology & Metabolism 100:12, pages 4396-4398.
Crossref
Crossref
Alma Linkeviciute, Fedro A. Peccatori, Virginia Sanchini & Giovanni Boniolo. (2015) Oocyte cryopreservation beyond cancer: tools for ethical reflection. Journal of Assisted Reproduction and Genetics 32:8, pages 1211-1220.
Crossref
Crossref
Oliver O'Donovan, Ali Al Chami & Melanie Davies. (2015) Ovarian hyperstimulation syndrome. Obstetrics, Gynaecology & Reproductive Medicine 25:2, pages 43-48.
Crossref
Crossref
Kazem Nouri, Clemens B Tempfer, Christian Lenart, Lisa Windischbauer, Katharina Walch, Regina Promberger & Johannes Ott. (2014) Predictive factors for recovery time in patients suffering from severe OHSS. Reproductive Biology and Endocrinology 12:1.
Crossref
Crossref
Dana Chuderland, Ido Ben-Ami, Hadas Bar-Joseph & Ruth Shalgi. (2014) Role of pigment epithelium-derived factor in the reproductive system. REPRODUCTION 148:4, pages R53-R61.
Crossref
Crossref
Ryan G. Steward, Lan Lan, Anish A. Shah, Jason S. Yeh, Thomas M. Price, James M. Goldfarb & Suheil J. Muasher. (2014) Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertility and Sterility 101:4, pages 967-973.
Crossref
Crossref
Travis J O’Brien, Arthur F Harralson, Tuyen Tran, Ian Gindoff, Funda E Orkunoglu-Suer, David Frankfurter & Paul Gindoff. (2014) Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome. Reproductive Biology and Endocrinology 12:1, pages 36.
Crossref
Crossref